Tag: Merge

Biocon Biologics and Biocon to Merge: Key Developments in the Biopharmaceutical Sector

Biocon to acquire balance stake in Biocon Biologics at EV of USD 5.5 billion Biocon announced a strategic corporate action to fully integrate Biocon Biologics (BBL) as a wholly owned subsidiary into Biocon, subject to applicable approvals. The Strategy Committee, constituted in May 2025, undertook a comprehensive evaluation of multiple strategic options for Biocon Biologics,…

December 6, 2025

► Necessary Cookies Standard

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

None

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

None

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

None

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

None

Biocon Biologics and Biocon to Merge: Key Developments in the Biopharmaceutical Sector